|
发表于 2009-9-17 05:15 PM
|
显示全部楼层
Arena to discuss study obesity drug study results
Arena Pharmaceuticals will discuss key study results for developing obesity drug on Friday
* On Thursday September 17, 2009, 4:54 pm EDT
o
Buzz up! 0
o Print
*
Companies:
o Arena Pharmaceuticals, Inc.
SAN DIEGO (AP) -- Arena Pharmaceuticals Inc. said it will hold a conference call Friday to discuss study results for its obesity drug candidate lorcaserin.
The late-stage study being discussed is called BLOSSOM.
The announcement of the conference call drove shares higher in after-hours trading. The stock rose $1.29, or 26 percent, to $6.20 in after-hours trading after rising 9 cents to close at $4.91 during the regular trading session.
In June, Arena said lorcaserin helped patients lose and keep off weight in updated data on a clinical trial. Results from the study, called BLOOM, were first reported in March. |
|